1. Home
  2. AAME vs FEMY Comparison

AAME vs FEMY Comparison

Compare AAME & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$2.44

Market Cap

50.6M

Sector

Finance

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.88

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAME
FEMY
Founded
1968
2004
Country
United States
United States
Employees
156
N/A
Industry
Life Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.6M
51.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AAME
FEMY
Price
$2.44
$0.88
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.83
AVG Volume (30 Days)
27.6K
1.9M
Earning Date
11-14-2025
11-14-2025
Dividend Yield
0.80%
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
$208,218,000.00
$2,061,502.00
Revenue This Year
N/A
$64.02
Revenue Next Year
N/A
$147.19
P/E Ratio
$10.78
N/A
Revenue Growth
11.99
63.53
52 Week Low
$1.25
$0.31
52 Week High
$3.71
$1.80

Technical Indicators

Market Signals
Indicator
AAME
FEMY
Relative Strength Index (RSI) 39.31 53.08
Support Level $2.34 $0.79
Resistance Level $2.62 $0.91
Average True Range (ATR) 0.14 0.07
MACD 0.02 -0.01
Stochastic Oscillator 21.64 34.37

Price Performance

Historical Comparison
AAME
FEMY

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: